Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease
- PMID: 9949631
Increased bcl-2/bax ratio in B-cell chronic lymphocytic leukemia is associated with a progressive pattern of disease
Abstract
In order to evaluate clinical implications of altered expression of bcl-2 and bax proteins in B-cell chronic lymphocytic leukemia (CLL) we studied 27 patients with this disease. Cytofluorometric levels of bcl-2 did not reflect the status of disease. In contrast bax expression was lower in progressive than in non-progressive disease, therefore leading to a higher bcl-2/bax ratio in patients of the former group. If confirmed in longitudinal studies, quantitative cytofluorometric evaluation of bcl-2 and bax protein might help to identify patients with progressive disease who could possibly benefit from early therapy.
Similar articles
-
Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.Lab Hematol. 2006;12(4):187-92. doi: 10.1532/LH96.06020. Lab Hematol. 2006. PMID: 17118768
-
Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.Am J Hematol. 2004 Jan;75(1):22-33. doi: 10.1002/ajh.10453. Am J Hematol. 2004. PMID: 14695629
-
Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.J Clin Oncol. 2003 Apr 15;21(8):1466-71. doi: 10.1200/JCO.2003.06.012. J Clin Oncol. 2003. PMID: 12697868
-
Molecular biology of chronic lymphocytic leukemia: implications for therapy.Semin Hematol. 1998 Jul;35(3 Suppl 3):3-13. Semin Hematol. 1998. PMID: 9685174 Review. No abstract available.
-
Autocrine and paracrine growth loops in chronic lymphocytic leukemia.Semin Hematol. 1993 Oct;30(4):306-17. Semin Hematol. 1993. PMID: 7505482 Review. No abstract available.
Cited by
-
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia.Haematologica. 2016 Jan;101(1):77-85. doi: 10.3324/haematol.2015.131854. Epub 2015 Nov 12. Haematologica. 2016. PMID: 26565002 Free PMC article.
-
Directly targeting BAX for drug discovery: Therapeutic opportunities and challenges.Acta Pharm Sin B. 2024 Jun;14(6):2378-2401. doi: 10.1016/j.apsb.2024.02.010. Epub 2024 Feb 10. Acta Pharm Sin B. 2024. PMID: 38828138 Free PMC article. Review.
-
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias.Adv Hematol. 2012;2012:524308. doi: 10.1155/2012/524308. Epub 2011 Sep 14. Adv Hematol. 2012. PMID: 21941553 Free PMC article.
-
Gene expression of INPP5F as an independent prognostic marker in fludarabine-based therapy of chronic lymphocytic leukemia.Blood Cancer J. 2015 Oct 2;5(10):e353. doi: 10.1038/bcj.2015.82. Blood Cancer J. 2015. PMID: 26430724 Free PMC article. Clinical Trial.
-
Bcl-2 and apoptosis in chronic lymphocytic leukemia.Curr Treat Options Oncol. 2003 Jun;4(3):211-8. doi: 10.1007/s11864-003-0022-y. Curr Treat Options Oncol. 2003. PMID: 12718798 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials